688136 Kexing Biopharm
- 16.90
- -0.32-1.86%
Kexing Biopharm News
Announcement on the ownership results and stock listing of the 2022 Restricted Stock Incentive Plan for the first grant of the second vesting period and the first vesting period reserved for the 2022 Restricted Stock Incentive Plan
Kexon Pharmaceuticals: Announcement of Resolutions of the 2024 Third Extraordinary General Meeting of Shareholders
Kexon Pharmaceuticals: Announcement on holding the results briefing for the third quarter of 2024
Kexing Pharmaceuticals: Legal Opinion of Beijing Jiayuan Law Firm on the 2024 Third Extraordinary General Meeting of Shareholders of Kexing Biopharmaceutical Co., Ltd.
Announcement on holding the results briefing for the third quarter of 2024
Legal Opinion of Beijing Jiayuan Law Firm on the 2024 Third Extraordinary General Meeting of Shareholders of Kexing Biopharmaceutical Co., Ltd.
Announcement of Resolutions of the 2024 Third Extraordinary General Meeting of Shareholders
Announcement of Resolutions of the 17th Meeting of the Second Board of Supervisors
Third Quarter Report 2024
Announcement on the reconsideration of related transaction agreements
2024 3rd Extraordinary General Meeting of Shareholders Meeting Materials
Kexon Pharmaceuticals: Voluntary disclosure of the announcement that injectable paclitaxel (albumin binding type) has obtained marketing approval in the UK
Voluntary disclosure of the announcement that paclitaxel for injectable use (albumin binding type) has obtained marketing approval in the UK
Notice on convening the 3rd Extraordinary General Meeting of Shareholders in 2024
Notice on the change of accounting firm
Announcement on attending the 2024 Semi-Annual Science and Technology Innovation Board Special Group Results Briefing on Pharmaceuticals and Biological Products
Kexing Biopharm's investor relations activity record form for August 2024
Announcement on the Rectification Report of the Administrative Supervision Measures Decision of Shandong Securities Regulatory Bureau.
Special report on the use and placement of funds raised in the first half of 2024.
Announcement Regarding the Termination of Some Daily Related Trade Agreements.
Analysis
Price Target
No Data
No Data